Wesley Chapel, FL, United States of America

Lixian Jiang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal4 out of 832,680 
Other
 patents

Years Active: 2013-2016

Loading Chart...
4 patents (USPTO):

Title: Lixian Jiang: Innovator in Oncolytic Virotherapy

Introduction

Lixian Jiang is a prominent inventor based in Wesley Chapel, FL (US). He has made significant contributions to the field of oncolytic virotherapy, particularly in the treatment of various cancers. With a total of 4 patents, Jiang's work focuses on utilizing engineered respiratory syncytial viruses to target and destroy cancer cells.

Latest Patents

One of Jiang's latest patents is titled "Lung cancer therapy using an engineered respiratory syncytial virus." This invention discloses an engineered oncolytic respiratory syncytial virus (RSV), specifically an NS1 gene deficient RSV, and its application in treating lung cancer by effectively killing cancer cells, supported by both in vitro and in vivo evidence. Another significant patent is "Prostate cancer therapy using an engineered respiratory syncytial virus." This invention falls within the realm of oncolytic virotherapy, which employs viruses, either naturally occurring or genetically modified, to selectively target and destroy tumor cells while sparing surrounding non-malignant cells. In this case, the engineered RSV, with the NS1 gene deleted, effectively kills prostate cancer cells without affecting normal human cells.

Career Highlights

Throughout his career, Lixian Jiang has demonstrated a commitment to advancing cancer treatment through innovative research and development. His work has the potential to significantly improve therapeutic options for patients suffering from lung and prostate cancers.

Collaborations

Jiang has collaborated with notable colleagues in his field, including Weidong Zhang and Calvin Cuong Cao. These partnerships have likely contributed to the success and impact of his research endeavors.

Conclusion

Lixian Jiang is a key figure in the development of oncolytic virotherapy, with a focus on engineered respiratory syncytial viruses for cancer treatment. His innovative patents and collaborative efforts highlight his dedication to improving cancer therapies and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…